Optimal schedule of adjuvant chemotherapy with S-1 for stage III colon cancer: study protocol for a randomized controlled trial

Autor: Yoshimura Kenichi, Uehara Keisuke, Tojima Yuichiro, Kawai Satoru, Mokuno Yasuji, Maeda Atsuyuki, Kyokane Takanori, Kobayashi Satoshi, Yoshioka Yuichiro, Nagino Masato

Publikováno v: Trials, Vol 14, Iss 1, p 17 (2013)

Abstract Background Although, in Western countries, oxaliplatin-based regimens have been established as a gold standard treatment for patients with stage III or high risk stage II colon cancer after curative resection, in Japan fluorouracil-based reg

Externí odkaz: https://doaj.org/article/f1ea1935ea2847899f80b621c4686dc9

NAK is an IKB kinase-activating kinase.

Autor: Tojima, Yuichiro, Fujimoto, Atsushi

Publikováno v: Nature. 4/13/2000, Vol. 404 Issue 6779, p778. 5p. 3 Color Photographs, 12 Diagrams, 9 Graphs.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Rupture of the common bile duct due to blunt trauma, presenting difficulty in diagnosis.

Autor: Ishida T; Surgery, National Cancer Center Japan, Chuo-ku, Japan.; Surgery, JCHO Chukyo Hospital, Nagoya, Japan., Hayashi E; Surgery, JCHO Chukyo Hospital, Nagoya, Japan., Tojima Y; Surgery, JCHO Chukyo Hospital, Nagoya, Japan., Sakakibara M; Surgery, JCHO Chukyo Hospital, Nagoya, Japan.; Vascular Surgery, Nagoya University Hospital, Nagoya, Japan.

Publikováno v: BMJ case reports [BMJ Case Rep] 2018 Dec 10; Vol. 11 (1). Date of Electronic Publication: 2018 Dec 10.